Clinical Trial Update: Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting safety and preliminary efficacy of recombinant activated factor VII to prevent early hematoma growth in acute intracereb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Bleeding Disorder
• Intracerebral Hemorrhage

Drugs mentioned

• NovoSeven RT (Recombinant activated factor VII)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Acquired Bleeding Disorder, Intracerebral Haemorrhage | Phase 2 | Status: COMPLETED